Lanthanide Complexes for MRI Contrast Agents
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current contrast agents for magnetic resonance imaging (MRI) and optical imaging lack simultaneous optimization of parameters for high relaxivity and stability, leading to suboptimal performance, and there is a scarcity of bifunctional agents with both good magnetic and optical properties.
Innovation Solution
Development of new lanthanide complexes with specific ligands, such as the N,N'-bis[(6-carboxypyridin-2-yl)methyl]-ethylenediamine-N,N'-diacetic acid ligand, which form stable, water-soluble complexes with gadolinium and terbium, exhibiting enhanced relaxivity and optical properties, allowing for effective complexation and slow electronic relaxation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If gadolinium is used in hydrated form to provide high relaxivity, then contrast agent performance improves, but toxicity increases
Solution Approach 1:
The patent introduces macrocyclic ligands as intermediary compounds that complex with gadolinium ions to form stable, non-toxic chelates. These ligands act as mediators between the toxic Gd³⁺ ions and the biological system, allowing the gadolinium to provide contrast enhancement while the ligand structure prevents toxicity by controlling the biodistribution and stability of the complex in physiological conditions.
2Stability of the object's composition
If poly(amino)carboxylate ligands are used to ensure stability, then kinetic and thermodynamic stability improve, but relaxivity decreases below theoretical maximum
Solution Approach 1:
The patent modifies the ligand structure by incorporating macrocyclic frameworks with specific cavity sizes and donor atom arrangements that optimize both stability and relaxivity. By changing the structural parameters of the ligand (macrocyclic ring size, number and position of donor atoms), the patent achieves simultaneous improvement in thermodynamic stability and water exchange kinetics, thereby maximizing relaxivity while maintaining complex stability.
3Stability of the object's composition
If ligands with high coordination number are used to increase stability, then complex stability improves, but number of coordinated water molecules decreases, reducing relaxivity
Solution Approach 1:
The patent designs ligands with differentiated local coordination environments where specific regions provide strong binding for stability while leaving dedicated sites for water coordination. The macrocyclic ligand structure creates distinct coordination spheres: some donor atoms form stable bonds with gadolinium while other regions maintain open or labile sites that can accommodate water molecules, thus simultaneously achieving high stability and maintained relaxivity.
4Reliability
If highly symmetric ligands are used to achieve rigid complexes, then electronic relaxation time increases, but coordination flexibility decreases
Solution Approach 1:
The patent employs macrocyclic ligands with inherent flexibility that allow dynamic adaptation of the coordination sphere. The ligand structure can adjust its conformation to accommodate different lanthanide ions while maintaining stable complexation, providing both the rigidity needed for slow electronic relaxation and the flexibility required for optimal coordination geometry adaptation across different metal centers.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The new lanthanide complexes demonstrate relaxivity comparable to commercial agents and remarkable optical properties, enabling improved imaging capabilities with increased depth penetration and sensitivity, suitable for both MRI and luminescence microscopy.
Implementation Method 1
Paramagnetic complexes of gadolinium(III) have established themselves as contrast agents due to the particular electronic and magnetic properties of this ion. Relaxivity is defined as the ability of a complex to increase the rate of relaxation of protons in surrounding water molecules.
Implementation Method 2
The preparation of stable, highly light-emitting lanthanide complexes in water requires the design of polydentate ligands containing photosensitizers capable of shielding the central metal of water molecules from the solvent to avoid nonradiative deactivation.
Data Source
Figure 1~2
Figure 3a~3b
Figure 4
AI summary
The present invention relates to a ligand for metals, in particular lanthanides, of general formula (I) in which A corresponds to an organic acid radical, or to an alkyl ester or an aryl ester, R1 and R2 correspond, individually and independently of one another, to an H, to an alkyl radical or to an aryl radical, Z1 and Z2, which may be identical or different, are of general formula (ZA) OR (ZB), in which: G represents an O, N, P, S or a C, independently substituted with an H, an alkyl radical or an aryl radical, and R3 to R8 correspond, individually and independently of one another, to an H, to an alkyl radical or to an aryl radical. The present invention also relates to coordination complexes of general formula in which: Ln is a lanthanide, L corresponds to a ligand, and also to the grafting thereof to a molecule of interest and to the process for the preparation thereof. The present invention also relates to a contrast agent and to a pharmaceutical composition containing at least one ligand and/or complex and/or molecule of interest.